These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16880359)

  • 1. Biomarkers in the diagnosis of Alzheimer's disease: are we ready?
    Sunderland T; Hampel H; Takeda M; Putnam KT; Cohen RM
    J Geriatr Psychiatry Neurol; 2006 Sep; 19(3):172-9. PubMed ID: 16880359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic issues in dementia: neuroimaging as a surrogate marker of disease.
    Small GW
    J Geriatr Psychiatry Neurol; 2006 Sep; 19(3):180-5. PubMed ID: 16880360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patients.
    Boccardi M; Nicolosi V; Festari C; Bianchetti A; Cappa S; Chiasserini D; Falini A; Guerra UP; Nobili F; Padovani A; Sancesario G; Morbelli S; Parnetti L; Tiraboschi P; Muscio C; Perani D; Pizzini FB; Beltramello A; Salvini Porro G; Ciaccio M; Schillaci O; Trabucchi M; Tagliavini F; Frisoni GB
    Eur J Neurol; 2020 Mar; 27(3):475-483. PubMed ID: 31692118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias.
    Scheltens P; Korf ES
    Curr Opin Neurol; 2000 Aug; 13(4):391-6. PubMed ID: 10970055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
    Ellis KA; Bush AI; Darby D; De Fazio D; Foster J; Hudson P; Lautenschlager NT; Lenzo N; Martins RN; Maruff P; Masters C; Milner A; Pike K; Rowe C; Savage G; Szoeke C; Taddei K; Villemagne V; Woodward M; Ames D;
    Int Psychogeriatr; 2009 Aug; 21(4):672-87. PubMed ID: 19470201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging for diagnosis of dementia.
    Small GW; Leiter F
    J Clin Psychiatry; 1998; 59 Suppl 11():4-7. PubMed ID: 9731543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and dementia nosology.
    Blacker D; Lovestone S
    J Geriatr Psychiatry Neurol; 2006 Sep; 19(3):186-91. PubMed ID: 16880361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Alzheimer's disease: two-decades of progress.
    Khachaturian ZS
    J Alzheimers Dis; 2006; 9(3 Suppl):409-15. PubMed ID: 16914879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological markers in the diagnosis of dementia and Alzheimer's disease].
    Meiner Z; Rosenmann H
    Harefuah; 2012 May; 151(5):289-93, 318. PubMed ID: 22844733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease.
    Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
    Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Alzheimer's disease neuroimaging initiative.
    Mueller SG; Weiner MW; Thal LJ; Petersen RC; Jack C; Jagust W; Trojanowski JQ; Toga AW; Beckett L
    Neuroimaging Clin N Am; 2005 Nov; 15(4):869-77, xi-xii. PubMed ID: 16443497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized medicine in Alzheimer's disease and depression.
    Souslova T; Marple TC; Spiekerman AM; Mohammad AA
    Contemp Clin Trials; 2013 Nov; 36(2):616-23. PubMed ID: 23816492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
    Mosconi L; De Santi S; Rusinek H; Convit A; de Leon MJ
    Expert Rev Neurother; 2004 Sep; 4(5):831-49. PubMed ID: 15853510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic markers in Alzheimer's disease].
    Martínez Lage JM
    Med Clin (Barc); 1997 Nov; 109(16):625-8. PubMed ID: 9463137
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of quantitative structural imaging in the early diagnosis of Alzheimer's disease.
    Glodzik-Sobanska L; Rusinek H; Mosconi L; Li Y; Zhan J; de Santi S; Convit A; Rich K; Brys M; de Leon MJ
    Neuroimaging Clin N Am; 2005 Nov; 15(4):803-26, x. PubMed ID: 16443492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
    Lista S; Garaci FG; Ewers M; Teipel S; Zetterberg H; Blennow K; Hampel H
    Alzheimers Dement; 2014 May; 10(3):381-92. PubMed ID: 23850330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.